| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |